938 reports of this reaction
2.0% of all LINEZOLID reports
#11 most reported adverse reaction
LACTIC ACIDOSIS is the #11 most commonly reported adverse reaction for LINEZOLID, manufactured by Hp Halden Pharma AS. There are 938 FDA adverse event reports linking LINEZOLID to LACTIC ACIDOSIS. This represents approximately 2.0% of all 47,534 adverse event reports for this drug.
Patients taking LINEZOLID who experience lactic acidosis should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
LACTIC ACIDOSIS is a less commonly reported adverse event for LINEZOLID, but still significant enough to appear in the safety profile.
In addition to lactic acidosis, the following adverse reactions have been reported for LINEZOLID:
The following drugs have also been linked to lactic acidosis in FDA adverse event reports:
LACTIC ACIDOSIS has been reported as an adverse event in 938 FDA reports for LINEZOLID. This does not prove causation, but indicates an association observed in post-market surveillance data.
LACTIC ACIDOSIS accounts for approximately 2.0% of all adverse event reports for LINEZOLID, making it a notable side effect.
If you experience lactic acidosis while taking LINEZOLID, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.